Highlights the urgent need for pharmacokinetic-pharmacodynamic modelling to establish optimal anticoagulant dosing regimens in obese patients.
No takes yet. Share an insight, caveat, or question.
Obese patients face uncertain anticoagulant dosing; leaves open optimal regimens pending dedicated PK-PD modeling.
Patel et al. (2011) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: